Frequentz and Optel Vision Partner to Optimize Global Drug Traceability
New Integration Delivers Advanced Track-and-Trace Features to Streamline Business Processes, Eliminate Product Mislabeling and Improve Consumer Safety
(firmenpresse) - DEL MAR, CA -- (Marketwired) -- 11/12/13 -- , a global leader in real-time traceability and information management software, today announced a partnership with Optel Vision, a provider of vision inspection solutions for packaging in the pharmaceutical, nutraceutical and cosmetics industries. The new partnership and intelligent product integration offers pharmaceutical manufacturers an end-to-end traceability solution to eliminate health risks associated with mislabeled and counterfeit drugs.
The partnership integrates Frequentz's Information Repository and Intelligence Server (IRIS), an event-driven traceability server built on technology acquired by IBM, with Optel Vision's serialization and traceability related offerings. The joint solution provides global pharmaceutical manufacturers with an automated, robust and scalable track-and-trace solution with data analytics capabilities that allow a manufacturer to identify and eliminate drug counterfeiting, reduce product mislabeling and improve overall compliance.
"The pharmaceutical industry is under increasing regulatory pressure to implement track-and-trace solutions to improve and ensure patient safety," said Michael Lucas, CEO, Frequentz. "Our partnership and full-scale product integration with Optel Vision empowers pharmaceutical manufacturers to achieve full compliance, and automates the track-and-trace process to ensure they can easily adapt to any future trace-related regulations."
Key benefits of the integration include:
Combining company strengths from the onset means shorter implementation time for clients
Both companies offer strongly tested and proven technologies
Frequentz's unique 0% Financing offering is now extended to Optel partners implementing a combined solution
True end-to-end solution capabilities, providing intelligence including predictive inventory and predictive analytics
"Partnering with Frequentz made perfect sense. The company shares Optel Vision's goal of aligning our products to the highest pharmaceutical practices to meet the GS1 Standards," said Louis Roy, president and CEO, Optel Vision. "We're excited to be able to offer our customers an integrated, out-of-the-box solution that not only helps them prepare for upcoming regulatory changes, but also allows them to protect the public against illicit product introduction within the supply chain."
Frequentz is a leader in comprehensive traceability and information management technologies that improve productivity, product quality, and profitability. Its solutions provide valuable insight into end-to-end supply chains, and critical business processes by collecting, storing and analyzing serialized, life history data. Applications of its software are currently used in the agricultural, pharmaceutical, retail, and automotive industries globally and promote intelligent analytics and consumer safety.
For more information visit: , or contact Glen Wellbrock directly at 858.461.4417.
Contacts:
Lauren Grassetti
LEWIS PR for Frequentz
619-677-2700
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.11.2013 - 15:18 Uhr
Sprache: Deutsch
News-ID 1282353
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
DEL MAR, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 138 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Frequentz and Optel Vision Partner to Optimize Global Drug Traceability
"
steht unter der journalistisch-redaktionellen Verantwortung von
Frequentz (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
